Indivumed

Indivumed is an integrated oncology company leveraging its leading oncology biorepository expertise with its pre-clinical, clinical and diagnostic laboratory expertise aiming to develop individualized cancer therapies. Indivumed provides products and services to obtain an in-depth understanding of the underlying mechanisms of a patients cancer and addresses several important demands in translational research and molecular diagnostics to support the implementation of personalized healthcare. Indivumed offers a unique combination of capabilities which can significantly contribute to the identification of new biomarkers and drug targets, to the development of novel companion diagnostics to guide treatment decisions, to the collection of information for defining the right treatment for every patients unique biology, and ultimately to the cure of cancer.